Effects of Josamycin on Scratching Behavior in NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions

Katsuhiko Matsui1, Midori Nakamura1, Noriko Obana1

  • 1Department of Clinical Immunology, Meiji Pharmaceutical University.

Insights

Topical antibiotic josamycin reduced Staphylococcus aureus (S. aureus) colonization and scratching behavior in mice with atopic dermatitis (AD)-like skin lesions. This treatment also decreased skin inflammation and IL-31, suggesting a link between S. aureus and AD itch.

Area of Science:

  • Dermatology
  • Microbiology
  • Immunology

Background:

  • Chronic Staphylococcus aureus (S. aureus) colonization worsens atopic dermatitis (AD) and inflammation.
  • The role of S. aureus in AD-associated pruritus (itch) remains unclear.

Purpose of the Study:

  • To investigate the effect of topical josamycin on scratching behavior in AD-like mouse models.
  • To assess josamycin's impact on S. aureus colonization, skin severity, and IL-31 expression.

Main Methods:

  • NC/Nga mice with Dermatophagoides farinae-induced AD-like lesions were treated with 0.1% josamycin ointment.
  • Evaluations included skin severity scores, S. aureus counts, scratching behavior, and IL-31 mRNA levels.

Main Results:

  • Josamycin significantly reduced skin severity scores in treated mice.
  • A decrease in S. aureus colonization, scratching behavior, and IL-31 mRNA expression was observed.
  • Results indicate a correlation between S. aureus levels, IL-31 production, and AD severity.

Conclusions:

  • Topical josamycin is effective in managing AD-like skin inflammation and pruritus.
  • Eliminating S. aureus with josamycin suppresses IL-31 production, alleviating itch in AD.
  • This suggests josamycin is a potential therapeutic for S. aureus-colonized AD lesions.

Related Concept Videos